KYTX
Price
$3.28
Change
-$0.19 (-5.48%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
141.76M
51 days until earnings call
OPT
Price
$3.41
Change
+$0.23 (+7.23%)
Updated
Mar 17 closing price
Capitalization
524.82M
61 days until earnings call
Interact to see
Advertisement

KYTX vs OPT

Header iconKYTX vs OPT Comparison
Open Charts KYTX vs OPTBanner chart's image
Kyverna Therapeutics
Price$3.28
Change-$0.19 (-5.48%)
Volume$7.23K
Capitalization141.76M
Opthea
Price$3.41
Change+$0.23 (+7.23%)
Volume$3.03K
Capitalization524.82M
KYTX vs OPT Comparison Chart in %
Loading...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYTX vs. OPT commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYTX is a StrongBuy and OPT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (KYTX: $3.28 vs. OPT: $3.41)
Brand notoriety: KYTX and OPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYTX: 719% vs. OPT: 100%
Market capitalization -- KYTX: $141.76M vs. OPT: $524.82M
KYTX [@Biotechnology] is valued at $141.76M. OPT’s [@Biotechnology] market capitalization is $524.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYTX’s FA Score shows that 0 FA rating(s) are green whileOPT’s FA Score has 0 green FA rating(s).

  • KYTX’s FA Score: 0 green, 5 red.
  • OPT’s FA Score: 0 green, 5 red.
According to our system of comparison, both KYTX and OPT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYTX’s TA Score shows that 6 TA indicator(s) are bullish.

  • KYTX’s TA Score: 6 bullish, 4 bearish.

Price Growth

KYTX (@Biotechnology) experienced а +6.84% price change this week, while OPT (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

KYTX is expected to report earnings on Aug 18, 2025.

OPT is expected to report earnings on Aug 28, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPT($525M) has a higher market cap than KYTX($142M). KYTX YTD gains are higher at: -12.299 vs. OPT (-13.176). KYTX has higher annual earnings (EBITDA): -143.14M vs. OPT (-218.88M). KYTX has more cash in the bank: 243M vs. OPT (132M). KYTX has less debt than OPT: KYTX (6.94M) vs OPT (157M). OPT has higher revenues than KYTX: OPT (87.7K) vs KYTX (0).
KYTXOPTKYTX / OPT
Capitalization142M525M27%
EBITDA-143.14M-218.88M65%
Gain YTD-12.299-13.17693%
P/E RatioN/AN/A-
Revenue087.7K-
Total Cash243M132M184%
Total Debt6.94M157M4%
FUNDAMENTALS RATINGS
OPT: Fundamental Ratings
OPT
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUEX19.370.22
+1.15%
NYLI PineStone U.S. Equity Class A
ARTHX24.940.09
+0.36%
Artisan Global Equity Investor
TRLCX23.39N/A
N/A
Nuveen Large Cap Value Retire
LGOAX39.59N/A
N/A
Patient Opportunity A
PQCCX9.47N/A
N/A
PGIM Quant Solutions Mid-Cap Index R6

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with IPSC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
-5.48%
IPSC - KYTX
50%
Loosely correlated
-5.74%
CRSP - KYTX
48%
Loosely correlated
+1.69%
IMNM - KYTX
46%
Loosely correlated
-0.11%
RXRX - KYTX
45%
Loosely correlated
-6.94%
TRDA - KYTX
44%
Loosely correlated
-1.57%
More

OPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPT has been loosely correlated with PSTV. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if OPT jumps, then PSTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPT
1D Price
Change %
OPT100%
N/A
PSTV - OPT
35%
Loosely correlated
-13.26%
TNYA - OPT
34%
Loosely correlated
-9.26%
CYTK - OPT
27%
Poorly correlated
-2.21%
KYTX - OPT
26%
Poorly correlated
-5.48%
QLGN - OPT
25%
Poorly correlated
+0.28%
More